Cystic fibrosis

Cystic fibrosis (CF) is a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity.

Hemolytic anemia

A type of anemia caused by premature destruction of red blood cells (hemolysis).


Total: 8

                       


(per page)
PMID (PMCID)
29225856
(5715418)
 OTHER
Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient.
Kerkhoff AD, Patrick L, Cornett P, Kleinhenz ME, Brondfield S.
Clin Case Rep. 2017;5(12):2059-2061.
Piperacillin-tazobactam is one of the most common causes of drug-induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF).
24005557
 FEMALE Adult
Hemolytic anemia as a result of piperacillin/tazobactam administration: a case report and discussion of pathophysiology.
Zanetti RC, Biswas AK.
Mil Med. 2013;178(9):e1045-7.
We report a case of a 19-year-old woman with cystic fibrosis who presented with hemolytic anemia during a course of piperacillin/tazobactam.
20213286
 FEMALE Young Adult
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Kunzmann S, Thomas W, Mayer B, Kuhn S, Hebestreit H.
Infection. 2010;38(2):131-4.
As piperacillin is commonly used in patients with cystic fibrosis, it is important to monitor the full-blood counts of patients during treatment with piperacillin and to be aware of the potential for hemolytic anemia to develop.
20589083
(2892651)
 OTHER
Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Bandara M, Seder DB, Garratty G, Leger RM, Zuckerman JB.
Case Rep Med. 2010;2010:161454.
Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
20589083
(2892651)
 OTHER
Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Bandara M, Seder DB, Garratty G, Leger RM, Zuckerman JB.
Case Rep Med. 2010;2010:161454.
We report a case of drug-induced immune hemolytic anemia (DIIHA) in an adult female with cystic fibrosis (CF), complicating routine treatment of a pulmonary exacerbation with intravenous piperacillin-tazobactam.
8156723
 MALE Infant, Newborn
Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening.
Wilfond BS, Farrell PM, Laxova A, Mischler E.
Clin Pediatr (Phila). 1994;33(1):2-7.
Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis.
1277693
 MALE Infant, Newborn
Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis. Consider this diagnosis even in absence of pulmonary symptoms.
Dolan TF Jr.
Clin Pediatr (Phila). 1976;15(7):597-600.
This is a report of five infants eventually proven to have cystic fibrosis of the pancreas, who presented with hemolytic anemia and edema.
1277693
 MALE Infant, Newborn
Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis. Consider this diagnosis even in absence of pulmonary symptoms.
Dolan TF Jr.
Clin Pediatr (Phila). 1976;15(7):597-600.
Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis.